Showing results (131-140 of 144) with videos related to
Sort By:
Pageof 15
Plos One|May 7, 2015
Temporal dynamics of stress-induced alternations of intrinsic amygdala connectivity and neuroendocrine levelsC W E M Quaedflieg, V van de Ven, T Meyer, et al.Journal of Behavior Therapy and Experimental Psychiatry|September 1, 1992
Somatic symptoms in social phobia: a treatment method based on rational emotive therapy and paradoxical interventionsP P Mersch, M Hildebrand, E H Lavy, et al.Behaviour Research and Therapy|January 1, 1989
The effect of hypocapnia on extinction of conditioned fear responsesG M van der Molen, M A van den Hout, H Merckelbach, et al.Memory (Hove, England)|February 1, 2024
The effects of eye movements on the content and characteristics of unpleasant autobiographical memories: an extended replication studyH I Meckling, M H Nauta, W J P J van Hout, et al.FEBS Letters|October 18, 2000
N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistanceL H Jensen, I Wessel, M Møller, et al.Cancer Research|October 23, 1997
Loss of amino acids 1490Lys-Ser-Lys1492 in the COOH-terminal region of topoisomerase IIalpha in human small cell lung cancer cells selected for resistance to etoposide results in an extranuclear enzyme localizationI Wessel, P B Jensen, J Falck, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|November 26, 1999
Self-mutilating behaviour of psychiatric inpatientsH L Nijman, M Dautzenberg, H L Merckelbach, et al.Cancer Research|July 23, 1999
Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoformI Wessel, L H Jensen, P B Jensen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 20, 2004
Psychological characteristics of patients with newly developed psychogenic seizuresT van Merode, M Twellaar, I A W Kotsopoulos, et al.Anti-Cancer Drug Design|October 12, 2002
Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell linesL Rothenborg-Jensen, H F Hansen, I Wessel, et al.Pageof 15